Moderna announced that it has filed a request with the FDA for Emergency Use Authorization of its Covid-19 vaccine in teens aged 12-17
of more than 3,700 patients the vaccine was 93% effective at preventing Covid-19 in teenagers who had received one dose, and 100% effective in teens who had received two doses. .
There were no serious safety concerns reported in the teen trial, with the most common side effects were injection site pain, headache, fatigue and chills. Earlier this week, Moderna also announced that it was asking regulators in the EU and Canada to authorize the use of its vaccine in teens., but has not said when those results will be available.Research shows that kids and teenagers generally have less severe symptoms from the Covid-19 virus than adults— but that doesn’t mean that they shouldn’t get vaccinated.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna asks FDA to clear Covid vaccine for adolescents 12 to 17If approved, it would likely dramatically expand the number of Covid vaccine shots available to middle and high school students ahead of the next school year.
Read more »
India data revision results in world’s highest daily Covid-19 death tollMany experts believe India’s death toll is several times higher than the official number. The previous world record was 5,527 in the US on February 12, also due to an upwards revision of earlier deaths.
Read more »
U.S. to Donate 500 Million Covid-19 Vaccine Doses to Lower-Income CountriesThe Biden administration expects 200 million Pfizer doses will go to other countries this year and 300 million more across the first half of 2022. They will be donated through the Covax global initiative.
Read more »
Covid-19: 'Our wedding changed more times than I can count'Couples set to get married and the wedding industry face an anxious wait for restrictions to ease.
Read more »
Why vaccinating the world against COVID-19 is a monumental undertakingNEW: As of June 1, 38.5% of all COVID vaccine doses had gone to just 16% of the world's population, according to an ABC News' analysis. Read more about the challenges of access and equity in the effort to inoculate the world against COVID:
Read more »
Ocugen to file for full U.S. approval of COVID-19 shot instead of EUAOcugen Inc (OCGN.O) said on Thursday it would no longer pursue an emergency use authorization for its COVID-19 vaccine candidate, Covaxin, and would instead aim to file for a full U.S. approval of the shot.
Read more »